Inhibition of Human Natural Killer Cell Activity by Platelet‐Derived Growth Factor (PDGF)
- 1 May 1991
- journal article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 33 (5), 521-532
- https://doi.org/10.1111/j.1365-3083.1991.tb02522.x
Abstract
We have previously reported that platelet-derived growth factor (PDGF) substantially inhibits human natural killer (NK) cell cytotoxicity, and that NK cells possess high-affinity surface binding sites for the PDGF-AB isoform. In this communication, we present direct evidence for the presence of A-type (alpha) PDGF receptors on human NK cells by demonstrating that human NK cells have approximately 150,000 high-affinity, surface binding sites for recombinant (r)PDGF-AA and approximately 300,000 high-affinity, surface binding sites for rPDGF-BB. This was determined by the competitive binding of 125I-labelled rPDGF-AA or 125I-labelled rPDGF-BB and homologous unlabelled rPDGF-AA or rPDGF-BB to FACS-sorted, CD16+ lymphoid (NK) cells, and Scatchard analysis of these data. In addition, we also demonstrate that the various isoforms of PDGF have differential effects on NK-cell cytotoxicity. Physiological quantities (100 ng/ml) of rPDGF-BB homodimers, highly purified PDGF-AB heterodimers from outdated platelets, and rPDGF-AB heterodimers substantially inhibited NK-cell cytotoxicity in both a dose- and time-dependent manner. In contrast, pretreatment of NK cells with equivalent nanogram amounts of rPDGF-AA homodimers resulted in a significantly weaker inhibitory effect on NK-cell cytotoxicity as compared with the PDGF-BB and PDGF-AB isoforms. The implications of these findings are discussed.Keywords
This publication has 55 references indexed in Scilit:
- Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes.JCI Insight, 1990
- Purification of PDGF-AB and PDGF-BB from human platelet extracts and identification of all three PDGF dimers in human plateletsBiochemistry, 1990
- A human glioma cell line secretes three structurally and functionally different dimeric forms of platelet‐derived growth factorEuropean Journal of Biochemistry, 1988
- Natural killer‐cell immunodeficiency in patients with chronic myelogenous leukemia. I. Analysis of the defect using the monoclonal antibodies HNK‐1 (LEU‐7) and B73.1International Journal of Cancer, 1986
- Inhibition of activity of human NK and K cells by simple sugars: Discrimination between binding and postbinding eventsClinical Immunology and Immunopathology, 1984
- Human Platelet-Derived Growth Factor (PDGF): Amino-Terminal Amino Acid SequenceScience, 1983
- Platelet-derived growth factor: Identification of constituent polypeptide chainsBiochemical and Biophysical Research Communications, 1982
- Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation.The Journal of Experimental Medicine, 1978
- A platelet factor stimulating human normal glial cellsExperimental Cell Research, 1976
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949